Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-002152
Filing Date
2021-03-01
Accepted
2021-03-01 16:07:19
Documents
101
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K idra-20201231x10k.htm   iXBRL 10-K 3276761
2 EX-4.21 idra-20201231xex4d21.htm EX-4.21 34603
3 EX-10.25 idra-20201231xex10d25.htm EX-10.25 20816
4 EX-10.26 idra-20201231xex10d26.htm EX-10.26 152742
5 EX-23.1 idra-20201231xex23d1.htm EX-23.1 27533
6 EX-31.1 idra-20201231xex31d1.htm EX-31.1 23365
7 EX-31.2 idra-20201231xex31d2.htm EX-31.2 23841
8 EX-32.1 idra-20201231xex32d1.htm EX-32.1 8131
9 EX-32.2 idra-20201231xex32d2.htm EX-32.2 8177
10 GRAPHIC idra-20201231xex10d25001.jpg GRAPHIC 4680
11 GRAPHIC idra-20201231x10k001.jpg GRAPHIC 4126
12 GRAPHIC idra-20201231x10k002.jpg GRAPHIC 2255
13 GRAPHIC idra-20201231x10k003.jpg GRAPHIC 2240
14 GRAPHIC idra-20201231x10k004.jpg GRAPHIC 2459
15 GRAPHIC idra-20201231x10k005.jpg GRAPHIC 2168
  Complete submission text file 0001558370-21-002152.txt   12196766

Data Files

Seq Description Document Type Size
16 EX-101.SCH idra-20201231.xsd EX-101.SCH 77843
17 EX-101.CAL idra-20201231_cal.xml EX-101.CAL 56598
18 EX-101.DEF idra-20201231_def.xml EX-101.DEF 290393
19 EX-101.LAB idra-20201231_lab.xml EX-101.LAB 605322
20 EX-101.PRE idra-20201231_pre.xml EX-101.PRE 521344
21 EXTRACTED XBRL INSTANCE DOCUMENT idra-20201231x10k_htm.xml XML 2249262
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31918 | Film No.: 21697741
SIC: 2836 Biological Products, (No Diagnostic Substances)